Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Leukemia, Myeloid, Acute 15Myelodysplastic Syndromes 10Recurrence 7Ovarian Neoplasms 7Multiple Myeloma 7Pancreatic Neoplasms 6Lymphoma 6Lymphoma, Non-Hodgkin 5Lymphoma, B-Cell 5Colorectal Neoplasms 5Burkitt Lymphoma 5Stomach Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hodgkin Disease 4Hematologic Neoplasms 4Sarcoma 3Osteosarcoma 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia, Biphenotypic, Acute 3Leukemia, B-Cell 3Leukemia 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urogenital Neoplasms 2Triple Negative Breast Neoplasms 2Thymoma 2

Interventions

Oxaliplatin 3Leucovorin 3Fluorouracil 3Capecitabine 3zolbetuximab 2trastuzumab deruxtecan 2pembrolizumab 2Ramucirumab 2Paclitaxel 2repotrectinib 1lenvatinib 1fludarabine 1enzalutamide 1durvalumab 1darolutamide 1aldesleukin 1Vinorelbine 1Radiosurgery 1Radiation 1Prednisone 1Prednisolone 1Positron-Emission Tomography 1Pemetrexed 1PF06821497 1Nivolumab 1Negative-Pressure Wound Therapy 1Microscopy, Confocal 1MORAb-202 1Irinotecan 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma × fludarabine × 30 days × Clear all
NCT02133196 2026-06-05

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
85 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Neoplasm Metastasis, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡